1 Page 1 2 Page 2 3 Preview 4 Complete
Page 1 of 4 (0%)

Please note that completion of this evaluation form is required to receive credits.

Please complete the evaluation by answering all questions.
The purpose of this evaluation is to improve our courses. Your response is sincerely appreciated.
*
*
This is required to receive your CEUs/Contact Hours. If you do not have an NABP e-Profile ID or are from outside of the United States, please enter N/A.
*

Each statement in this section of the program evaluation is based on a seven (7) point scale. There are 20 statements requiring your evaluation.

*
Strongly AgreeAgreeSomewhat AgreeNeither Agree nor DisagreeSomewhat DisagreeDisagreeStrongly Disagree
The FDA regulatory framework and USP <797>, 2023 standards of practice applicable to compounding.
Personnel training and evaluation, and roles and responsibilities as outlined in USP <797>, § 2, 2023.
Standard Operating Procedures and related Documentation as identified throughout USP <797>, 2023.
The different characteristics related to immediate-use, Category 1, Category 2, and Category 3 compounding.
Facility and engineering controls related to sterile compounding as outlined in USP <797> § 4 & 5, 2023.
Microbiological air and surface monitoring as outlined in USP <797> § 6, 2023.
Equipment, supplies, and component handling, and management as outlined in USP <797> § 9, 2023.
Cleaning and disinfecting as outlined in USP <797> § 6, 2023.
Pharmaceutical calculations related to sterile dosage forms.
Aseptic processing, and release inspection and testing.
Quality Assurance and Quality Control procedures, activities, and oversight as outlined in USP <797>, § 18, 2023.
CSP Handling, storage, packaging, shipping, and transport as outlined in USP <797> § 19, 2023.
The compounding and management of Allergenic Extracts.
Hazard communication program, and API risk management as identified in USP <800>, 2020.
Standard Operating Procedures and related Documentation as identified throughout USP <800>, 2020.
Personal protective equipment and containment-engineering controls for hazardous drug compounding.
Deactivating, decontaminating, cleaning, and disinfecting for hazardous drug compounding.
Environmental wipe sampling for hazardous drug compounding.
Labeling, packaging, transport, and disposal of hazardous drugs.
Dispensing, compounding, and administering hazardous CSPs.